UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Outcomes after cryoablation vs. radiofrequency in patients with paroxysmal atrial fibrillation: impact of pulmonary veins anatomy

Europace (London, England), 2016-09, Vol.18 (9), p.1343-1351

2016

Volltextzugriff (PDF)

Low voltage area in the left atrial anterior wall predict Marshall-PLAN failure in patients with persistent atrial fibrillation

Europace (London, England), 2024-05, Vol.26 (Supplement_1)

2024

Volltextzugriff (PDF)

Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation

Europace (London, England), 2015-02, Vol.17 (2), p.225-231

2015

Volltextzugriff (PDF)

A multicentered evaluation of the waiting period after PVI guided by the Ablation Index

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

36Derivation of a prediction model for the optimization of patient selection for catheter ablation of atrial fibrillation: the AF-FREEDOM score

Europace (London, England), 2017-10, Vol.19 (suppl_1), p.i16-i16

2017

Volltextzugriff (PDF)

P1430The HATCH score does not predict FREEDOM from Atrial Fibrillation relapse following catheter ablation: Development of a novel stratifying tool

Europace (London, England), 2017-06, Vol.19 (suppl_3), p.iii285-iii285

2017

Volltextzugriff (PDF)

P1115Pacemaker-detected non sustained ventricular tachycardia is an early predictor of short-term hospitalization for heart failure

Europace (London, England), 2018-03, Vol.20 (suppl_1), p.i207-i207

2018

Volltextzugriff (PDF)

TRPM4 channel re-expression after myocardial infarction is essential for survival in mice

European heart journal, 2013-08, Vol.34 (suppl 1), p.P5015-P5015

2013

Volltextzugriff (PDF)

Leadless pacemaker implantation in young adults with vasovagal syncope and major cardioinhibitory component: About 2 cases

Archives of Cardiovascular Diseases Supplements, 2018-01, Vol.10 (1), p.101-101

2018

Volltextzugriff (PDF)

443 - Is adherence to non AVK therapy improved by a personnalized information program? A first look to MONACO study

Archives of Cardiovascular Diseases Supplements, 2017-01, Vol.9 (1), p.82-82

2017

Volltextzugriff (PDF)

Device-detected silent atrial fibrillation is associated to a high hospitalization rate for heart failure

Archives of cardiovascular diseases supplements, 2017-01, Vol.9 (1), p.80

2017

Volltextzugriff (PDF)

441 - Device-detected silent atrial fibrillation is associated to a high hospitalization rate for heart failure

Archives of Cardiovascular Diseases Supplements, 2017-01, Vol.9 (1), p.80-80

2017

Volltextzugriff (PDF)

Is adherence to non AVK therapy improved by a personnalized information program? A first look to MONACO study

Archives of cardiovascular diseases supplements, 2017-01, Vol.9 (1), p.82

2017

Volltextzugriff (PDF)

Cardiac tamponnade likely due to candida infection, in an immuno-competent patient

Annales de cardiologie et d'angéiologie, 2013-04, Vol.62 (2), p.122-123

2013

Volltextzugriff (PDF)

Cardiac tamponade likely due to candida infection, in an immunocompetent patient

Annales de cardiologie et d'angeiologie, 2013-04, Vol.62 (2), p.122-123

2013

Volltextzugriff (PDF)

CYP2R1 polymorphisms are important modulators of circulating 25-hydroxyvitamin D levels in elderly females with vitamin insufficiency, but not of the response to vitamin D supplementation

Osteoporosis international, 2017, Vol.28 (1), p.279-290

2017

Volltextzugriff (PDF)

Assessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2018-10, Vol.29, p.viii237-viii237

2018

Volltextzugriff (PDF)

Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population

PloS one, 2020-11, Vol.15 (11), p.e0242793-e0242793

2020

Volltextzugriff (PDF)

Abstract No. 37 LEAP-012 trial in progress: pembrolizumab, lenvatinib, and transarterial chemoembolization combination therapy for intermediate-stage hepatocellular carcinoma not amenable to curative treatment

Journal of vascular and interventional radiology, 2021-05, Vol.32 (5), p.S17

2021

Volltextzugriff (PDF)

P-107 LEAP-012: A randomized, double-blind, phase 3 study of pembrolizumab plus lenvatinib in combination with transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma not amenable to curative treatment

Annals of oncology, 2020-07, Vol.31, p.S124-S125

2020

Volltextzugriff (PDF)

703PAssessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a Lebanese population: frequency distribution and association with morbid diseases

Genetic testing and molecular biomarkers, 2010-06, Vol.14 (3), p.393

2010

Volltextzugriff (PDF)

420 Population pharmacokinetic and pharmacodynamic modelling of E7820 in patients with solid tumor

European journal of cancer supplements, 2010, Vol.8 (7), p.133-133

2010

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcomes after cryoablation vs. radiofrequency in patients with paroxysmal atrial fibrillation: impact of pulmonary veins anatomy

Low voltage area in the left atrial anterior wall predict Marshall-PLAN failure in patients with persistent atrial fibrillation

Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation

A multicentered evaluation of the waiting period after PVI guided by the Ablation Index

36Derivation of a prediction model for the optimization of patient selection for catheter ablation of atrial fibrillation: the AF-FREEDOM score

P1430The HATCH score does not predict FREEDOM from Atrial Fibrillation relapse following catheter ablation: Development of a novel stratifying tool

P1115Pacemaker-detected non sustained ventricular tachycardia is an early predictor of short-term hospitalization for heart failure

TRPM4 channel re-expression after myocardial infarction is essential for survival in mice

Leadless pacemaker implantation in young adults with vasovagal syncope and major cardioinhibitory component: About 2 cases

443 - Is adherence to non AVK therapy improved by a personnalized information program? A first look to MONACO study

Device-detected silent atrial fibrillation is associated to a high hospitalization rate for heart failure

441 - Device-detected silent atrial fibrillation is associated to a high hospitalization rate for heart failure

Is adherence to non AVK therapy improved by a personnalized information program? A first look to MONACO study

Cardiac tamponnade likely due to candida infection, in an immuno-competent patient

Cardiac tamponade likely due to candida infection, in an immunocompetent patient

CYP2R1 polymorphisms are important modulators of circulating 25-hydroxyvitamin D levels in elderly females with vitamin insufficiency, but not of the response to vitamin D supplementation

Assessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)

Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population

Abstract No. 37 LEAP-012 trial in progress: pembrolizumab, lenvatinib, and transarterial chemoembolization combination therapy for intermediate-stage hepatocellular carcinoma not amenable to curative treatment

P-107 LEAP-012: A randomized, double-blind, phase 3 study of pembrolizumab plus lenvatinib in combination with transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma not amenable to curative treatment

703PAssessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)

Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a Lebanese population: frequency distribution and association with morbid diseases

420 Population pharmacokinetic and pharmacodynamic modelling of E7820 in patients with solid tumor

Suchergebnisse filtern